WASHINGTON/NEW YORK (Reuters) -Vince McMahon, the former chief executive of World Wrestling Entertainment (NYSE:TKO), agreed to pay more than $1.7
Investing.com – Turkey stocks were lower after the close on Friday, as losses in the Leasing & Factoring, Banking and Holdings &
Investing.com — The Supreme Court will begin hearing arguments today regarding a law that could lead to a ban or sale of
Friday’s trading session is showcasing a notable shuffle among stocks across the board, with certain mega-cap and large-cap stocks experiencing significant intra-day
By Andrew Chung, John Kruzel and David Shepardson WASHINGTON (Reuters) -The Supreme Court began hearing arguments on Friday over the legality of a
By Manas Mishra and Sneha S K (Reuters) -Walgreens Boots Alliance beat analysts’ lowered expectations for first-quarter adjusted profit on Friday and indicated
The Federal Reserve is not expected to reduce interest rates soon, according to Nigel Green, CEO of deVere Group, following a robust
By Carolyn Cohn and Iain Withers LONDON (Reuters) – Some British pension funds are being told by asset managers to come up with
Investing.com — Shares of Intra-Cellular Therapies (NASDAQ:ITCI), a biopharmaceutical company, saw an increase of up to 19%, reaching an intraday record. This
By Nupur Anand and Isla Binnie (Reuters) – Wall Street giant JPMorgan Chase (NYSE:JPM) asked its employees who are on hybrid work schedules
By Laila Kearney and Seher Dareen NEW YORK (Reuters) – U.S. nuclear power provider Constellation Energy (NASDAQ:CEG) on Friday agreed to
By Ismail Shakil OTTAWA (Reuters) – Canada’s economy added nearly quadruple the number of jobs forecasted for December and the unemployment rate surprisingly
Investing.com — The release of strong US payrolls data has prompted traders to adjust their expectations for the next Federal Reserve rate
(Reuters) – Traders on Friday bet the Federal Reserve will wait until at least June to reduce its policy rate, and end
WASHINGTON (Reuters) – The U.S. Senate Finance Committee on Friday said it will hold a Jan. 16 nomination hearing on President-elect Donald
Investing.com — Shares of Apellis Pharmaceuticals (NASDAQ:APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application
